港股医药股走强 昭衍新药涨近4%

Group 1 - The core viewpoint of the article highlights the strong performance of Hong Kong pharmaceutical stocks on March 6, with specific companies showing notable gains [1][2] Group 2 - Zhaoyan New Drug (06127.HK) increased by 3.60% [1] - Weiya Biotechnology (01873.HK) rose by 2.87% [1] - King’s Ray Bio (01548.HK) saw a gain of 1.75% [1]